Estrogen in Patients with Prostatic Cancer An Assessment of the Risks and Benefits
- 1 January 1991
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 6 (1) , 47-53
- https://doi.org/10.2165/00002018-199106010-00005
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002
- Cardiovascular follow‐up of patients with prostatic cancer treated with single‐drug polyestradiol phosphateThe Prostate, 1987
- Steroid‐sensitive proteins, growth hormone and somatomedin C in prostatic cancer: Effects of parenteral and oral estrogen therapyThe Prostate, 1986
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral ContraceptivesNew England Journal of Medicine, 1981
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Selecting optimal treatment in clinical trials using covariate informationJournal of Chronic Diseases, 1977